Bavarian Nordic CEO notes progress in vaccine funding talks with Danish government
Monday, Bavarian Nordic presented promising data for the company's Covid-19 vaccine candidate. Danish state aid could play a role in helping the vaccine reach the public, and the firm's CEO says the talks are going well.
BY ANDREAS LØNSTRUP, TRANSLATED BY DANIEL FRANK CHRISTENSEN
The prospect of a Danish vaccine against Covid-19 is now one step closer to reality on Monday, when pharmaceutical company Bavarian Nordic presented a bundle of promising data. At the same time, the firm's talks with the Danish government concerning state financial support for the vaccine are progressing well, says Bavarian Nordic Chief Executive Paul Chaplien, reports Danish business daily Børsen.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Experts: The world needs more than just mRNA vaccines
For subscribers
.jpg&w=384&q=75)
